Thomas S Lin

Thomas S Lin

UNVERIFIED PROFILE

Are you Thomas S Lin?   Register this Author

Register author
Thomas S Lin

Thomas S Lin

Publications by authors named "Thomas S Lin"

Are you Thomas S Lin?   Register this Author

68Publications

1297Reads

14Profile Views

Long-term follow-up of previously treated and treatment-naïve patients who received tositumomab and I-131 tositumomab.

Leuk Lymphoma 2016 May 23;57(5):1238-40. Epub 2015 Dec 23.

d Janssen Pharmaceuticals , Horsham , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1082179DOI Listing
May 2016

CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2016 Apr 4;16(4):191-6. Epub 2016 Jan 4.

GlaxoSmithKline, Collegeville, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.12.011DOI Listing
April 2016

Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.

J Nucl Med 2015 Nov 3;56(11):1800-3. Epub 2015 Sep 3.

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.156190DOI Listing
November 2015

Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab.

Leuk Lymphoma 2015 Mar 23;56(3):779-81. Epub 2014 Jul 23.

St. Mary Medical Center , Walla Walla, WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.927461DOI Listing
March 2015

A phase I trial of flavopiridol in relapsed multiple myeloma.

Cancer Chemother Pharmacol 2014 Feb 16;73(2):249-57. Epub 2013 Nov 16.

Division of Hematology, The Ohio State University, B321 Starling Loving Hall, 320 West 10th Avenue, Columbus, OH, 43210, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2347-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946636PMC
February 2014

Ofatumumab: a novel monoclonal anti-CD20 antibody.

Authors:
Thomas S Lin

Pharmgenomics Pers Med 2010 10;3:51-9. Epub 2010 May 10.

GlaxoSmithKline Oncology R&D, Collegeville, PA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513208PMC
December 2012

17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition.

Blood 2010 Jul 29;116(1):45-53. Epub 2010 Mar 29.

Department of Internal Medicine, Division of Hematology and Oncology, Comprehensive Cancer Center at the Ohio State University, 410West 12th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-01-263756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904580PMC
July 2010

Flavopiridol in chronic lymphocytic leukemia: a concise review.

Clin Lymphoma Myeloma 2009 ;9 Suppl 3:S179-85

Division of Hematology-Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15579190117033
Publisher Site
http://dx.doi.org/10.3816/CLM.2009.s.009DOI Listing
January 2010

New agents in chronic lymphocytic leukemia.

Authors:
Thomas S Lin

Curr Hematol Malig Rep 2010 Jan;5(1):29-34

GlaxoSmithKline, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-009-0039-9DOI Listing
January 2010

Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemia.

Leuk Lymphoma 2009 Dec;50(12):1977-82

Division of Hematology-Oncology, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903288464DOI Listing
December 2009

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

Br J Haematol 2009 Sep 10;146(6):660-4. Epub 2009 Jul 10.

Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2009.07811.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2009.07811.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777697PMC
September 2009

Update in the management of chronic lymphocytic leukemia.

J Hematol Oncol 2009 Jul 20;2:29. Epub 2009 Jul 20.

The Ohio State University, Division of Hematology-Oncology, 320 West 10th Avenue, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-8722-2-29DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723130PMC
July 2009

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.

Biol Blood Marrow Transplant 2009 May 9;15(5):547-53. Epub 2009 Mar 9.

Hematology and Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953134PMC
May 2009

Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.

Leuk Lymphoma 2009 Mar;50(3):349-56

Division of Hematology-Oncology, Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190902730227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695225PMC
March 2009

High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Eur J Haematol 2008 Dec 4;81(6):425-31. Epub 2008 Sep 4.

Department of Internal Medicine, Division of Hematology-Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2008.01146.xDOI Listing
December 2008

Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Leuk Lymphoma 2008 Oct;49(10):1893-8

Department of Hematology and Oncology and Bone Marrow Transplantation, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819080227090
Publisher Site
http://dx.doi.org/10.1080/10428190802270902DOI Listing
October 2008

Novel agents in chronic lymphocytic leukemia: efficacy and tolerability of new therapies.

Authors:
Thomas S Lin

Clin Lymphoma Myeloma 2008 Aug;8 Suppl 4:S137-43

Division of Hematology and Oncology, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2008.s.009DOI Listing
August 2008

Lenalidomide: what is the right dose in CLL?

Authors:
Thomas S Lin

Blood 2008 Jun;111(11):5268

The Ohio State University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-03-146878DOI Listing
June 2008

Antibody therapy for chronic lymphocytic leukemia.

Semin Hematol 2008 Apr;45(2):95-103

Division of Hematology and Oncology, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2008.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2390995PMC
April 2008

Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia.

Br J Haematol 2007 Dec 19;139(5):837-44. Epub 2007 Oct 19.

Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2141.2007.06878.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2141.2007.06878.xDOI Listing
December 2007

Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteria.

J Clin Oncol 2007 Dec 5;25(35):5624-9. Epub 2007 Nov 5.

The Ohio State University, Division of Hematology-Oncology, Starling Loving Hall, Room B324, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.12.1152DOI Listing
December 2007

What is the optimal initial treatment for chronic lymphocytic leukemia?

Authors:
Thomas S Lin

Oncology (Williston Park) 2007 Dec;21(14):1641-9; discussion 1649-54, 1659, 1662

The Ohio State University, Division of Hematology and Oncology, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
December 2007

Flavopiridol in the treatment of chronic lymphocytic leukemia.

Curr Opin Oncol 2007 Nov;19(6):573-8

Division of Hematology and Oncology, Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e3282efb9daDOI Listing
November 2007

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma.

Leuk Res 2007 Aug 30;31(8):1069-75. Epub 2006 Oct 30.

Division of Hematology and Oncology, Department of Internal Medicine, The Ohio State University College of Medicine, Comprehensive Cancer Center, Starling-Loving Hall, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2006.09.021DOI Listing
August 2007

Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.

Semin Oncol 2006 Apr;33(2):210-9

Division of Hematology and Oncology, The Ohio State University, The Arthur James Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2006.01.012DOI Listing
April 2006

Changing the way we think about chronic lymphocytic leukemia.

J Clin Oncol 2005 Jun 14;23(18):4009-12. Epub 2005 Mar 14.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.08.964
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.08.964DOI Listing
June 2005

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia.

Blood 2005 Feb 5;105(3):959-67. Epub 2004 Oct 5.

Department of Internal Medicine, Division of Hematology-Oncology, Starling Loving Hall, Rm 302, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-05-1693DOI Listing
February 2005

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia.

Blood 2005 Jan 24;105(1):289-91. Epub 2004 Jun 24.

Department of Medicine, Division of Hematology-Oncology, The Ohio State University, Columbus 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-02-0651DOI Listing
January 2005

Monoclonal antibody therapy in lymphoid leukemias.

Adv Pharmacol 2004 ;51:127-67

Division of Hematology and Oncology, The Ohio State University, The Arthur James Comprehensive Cancer Center, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10543589045100
Publisher Site
http://dx.doi.org/10.1016/S1054-3589(04)51006-2DOI Listing
December 2004

Antibody therapy for chronic lymphocytic leukemia: a promising new modality.

Hematol Oncol Clin North Am 2004 Aug;18(4):895-913, ix-x

Division of Hematology and Oncology, Starling Loving Hall, Room 302, The Arthur James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S088985880400042
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2004.04.008DOI Listing
August 2004

Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells.

Blood 2004 Mar 20;103(5):1846-54. Epub 2003 Nov 20.

Division of Hematology-Oncology, The Ohio State University, Columbus 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-08-2836DOI Listing
March 2004

Rituximab in B-cell chronic lymphocytic leukemia.

Semin Oncol 2003 Aug;30(4):483-92

The Ohio State University, The Arthur James Comprehensive Cancer Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
August 2003

Autologous stem cell transplantation for non-Hodgkin's lymphoma.

Curr Hematol Rep 2003 Jul;2(4):310-5

Division of Hematology and Oncology, Ohio State University, 320 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
July 2003

Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.

Transplantation 2002 Jul;74(1):49-54

Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00007890-200207150-00009DOI Listing
July 2002

Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma.

Leuk Lymphoma 2002 Apr;43(4):793-7

Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190290016908DOI Listing
April 2002